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ABSTRACT
Lung cancer is the leading cause of cancer deaths in the world. For the year 2020, it was
estimated 1.8 million deaths were due to lung cancer alone, making it more lethal than breast
cancer and prostate cancer combined. For the year 2021, it is estimated 235,760 new cases of
lung cancer and 50% will lead to death. The primary cause of lung cancer is due to cigarette
smoking, which accounts for 80% of all lung cancer deaths. Lung cancer screening relies on only
different methods, biopsy, bronchoscopy, ultrasound, chest x-ray film, and sputum cytology.
These techniques are used to analyze the lungs for any abnormalities. The treatments available
for lung cancer rely on chemotherapy agents which are invasive and ineffective.
Nanotechnology, particularly gold nanoparticles have properties enabling them to be applied as
imaging tools for tumor detection, as delivery systems for targeted drug delivery, and as
therapeutic agents for photodynamic and photothermal therapy for eradicating cancerous cells.
This study focuses on the application of gold nanoshells as targeted agents for improving lung
cancer treatment. Gold nanoshells have great potential as a photothermal agent due to their
localized surface plasmon resonance properties, heat conservation, and surface chemistry. In this
study, gold-silica nanoshells of 120 nm in size were synthesized and incubated with the A549
human adenocarcinoma alveolar epithelial cell lines. Upon exposure to near-infrared resonance
(NIR) laser light (850 nm), the cells underwent photothermal cellular damage and reduction of
lung cell carcinoma viability compared to control cells. Research on this current topic will bring
further knowledge as more exploration is made on synthesizing gold nanoparticles for their use
in clinical studies.
v

CHAPTER ONE:
INTRODUCTION

1.1 Lung Cancer
1.1.1 Lung Cancer Statistics
Lung cancer is an abnormal growth of cells that begins in the lung and can spread throughout
other tissues and organs [1]. It is the leading cause of cancer deaths in the world and 80% of lung
cancer deaths are due to smoking [2]. The American Cancer Society estimates 228,820 cases of
lung cancer in 2020 and over 50% of these cases will result in deaths [3]. There are two types of
lung cancers: small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). NSCLC
accounts for 85% of lung cancer and the primary cause is cigarette smoking [4, 5], primarily
linked with over 20 years of smoking history [6]. The secondary leading cause of lung cancer is
exposure to radon gas. Radon gas is a radioactive gas produced when the element radium 226
decays. Another cause of lung cancer is due to prolonged exposure to carcinogens. Asbestos is a
carcinogenic compound produced from natural minerals can lead to chronic lung disease when
tiny fibers of asbestos are inhaled [7, 8]. Lida Gharibvand et al have found considerable positive
associations between lung cancer and particulate matter with an aerodynamic diameter of 2.5
mm (PM 2.5). Non-smokers exposed to PM2.5 had an increased risk of developing lung cancer [9].
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1.1.2 Pathophysiology of Lung Cancer
It can be difficult to properly diagnose lung cancer as the tumor can take several years to
show any signs of symptoms, [10] resulting in poor patient prognosis and poor treatment
methods [11]. Lung cancer is invasive and heterogenous; certain symptoms of lung cancer are
depending on the tumor anatomic growth, and symptoms usually show in later stages of the
tumor. Symptoms of lung cancer include constant and progressing cough, chest pain, lung
infection (pneumonia or bronchitis), hoarseness, and shortness of breath [12]. These symptoms
are common in both types of lung cancers. Lung cancer is categorized into NSCLC and SCLC
based on the physical characteristics of the tumor cells under a microscope [13]. NSCLC is the
most common and takes slower times to grow. It is subdivided into four stages (stage I, II, III,
and IV) and three different classes: squamous cell lung cancer, adenocarcinoma, and large
anaplastic carcinomas [4, 13]. Squamous cell lung cancer (SQCLC) accounts for 25-30% of lung
cancer, which arises in the main bronchi [6]. Adenocarcinoma (AdenoCA) accounts for 40% of
lung cancer, arises in the peripheral bronchi [6]. Large cell anaplastic carcinoma (LCAC)
accounts for 10% of lung cancers and is due to the absence of classic glandular [6]. SCLC is not
as common; however, it is solely present in heavier smokers. SCLC begins from the middle of
the chest particularly the bronchi and spread rapidly to nearby organs. SCLC has been classified
as small cell carcinoma and combined small cell carcinoma [4].
The stages of NSCLC are determined by how the tumor spreads to a localized area, how
the tumor spread to nearby lymph nodes, and the size of the tumor [14]. Lung cancer screening
relies on only two methods, chest x-ray film, and sputum cytology [11]. Both of these two
techniques are used to analyze the lungs during the pre-symptomatic and early stages. Physicians
may further prescribe and conduct biopsies, bronchoscopies, and ultrasound to accurately
2

diagnose the tumor stage and class [11]. Understanding the characteristics of the tumor location,
molecular abnormalities, and patient’s genetic information is essential for diagnosing treatment,
and prognosis [6]. Currently, NSCLC treatments include but not limited to radiation therapy
(radiotherapy), chemotherapy, chemoradiation, surgery, whole-brain radiotherapy (WBRT), and
targeted therapy [6]. Differential treatment depends on the tumor stages. Treatment for earlystage cancer (Stage I and II) typically is surgery to eradicate the tumor [6]. Treatments for stage
III and IV are surgery followed by chemotherapy and therapy (radiotherapy, chemotherapy, or
targeted therapy) [6].
1.2. Limitations of Conventional Lung Cancer Treatment and Detection:
There are several limitations to using conventional cancer treatments as they pose
numerous complications by increasing patient mortality rates [15]. Conventional therapy is
invasive and leads to healthy cells and tissue damage, kidney disease, heart disease, and
neuropathy [15]. Treatment methods for cancerous cells are based on the various stages of
cancer. The most common treatments are chemotherapy and radiotherapy, which are often used
together. The effectiveness of both therapies depends on the medical history of the patient, the
patient genetic information, the stages of the tumor, the location of the tumor, and the types of
treatments used [16]. Different parameters are taken into account when patients undergo therapy,
such as the type and size of the tumor, the radiation dose, and the length of the treatment.
Patients with early stages have higher survival rates than patients with advanced stages as they
are more responsive to treatments. When treating cancerous patients, the drug dose is
proportional to the response effect. A higher dose will result in a higher chance to cure or treat
the tumor [16]. However, a higher dose can potentially destroy the surrounded healthy tissues
and cells leading to morbidity [16]. Using nanotechnology as an alternative treatment can
3

minimize treatment side-effects, increase patients' survival rates, and improve cancer diagnosis
and treatment [50].
1.3. The Role of Nanotechnology in Cancer Detection and Treatment
Nanotechnology is an emerging field in science defined as the use or manipulation of
materials where at least one dimension is between 1 and 100 nm in size. Nanotechnology has
numerous advantages in biomedicine; it has been used as both a diagnostic and therapeutic tool.
Nanomaterials such as gold nanoparticles and quantum dots have optical, biodegradable, and
biocompatible properties to act as molecular imaging agents for in vitro detection of biological
molecules and tumors [52,53]. Other nanomaterials like dendrimers, nanowires, magnetic
nanoparticles, and carbon nanotubes are used as biosensors and drug delivery systems to target
cancerous cells [53].
Nanotechnology can enhance tumor targeting due to the ability to differentiate between
cancerous cells and non-cancerous cells, and selectively target cancerous cells actively or
passively. Active targeting involves cellular surface modalities recognition. In passive targeting,
cancerous tumors lack lymphatic drainage and experience hypervascularization leading to
increased permeability of drugs, proteins. Certain drugs administered for lung cancer have
difficulty targeting the cancerous cells, whereas passive targeting enables an increased
concentration of nanotechnology in the cells through enhancing permeability effect (or EPR
effect) [17,18]. Conventional drug formulations face major delivery problems as they have low
bioavailability and solubility. Before a drug reaches the tumor site, its concentration is likely to
be decreased leading to an increase of toxicity in non-localized tumor sites. Nanocarriers such as
liposomes, micelles, gold nanoparticles, carbon nanotubes, quantum dots, and solid lipid
dendrimers can improve delivery methods as they possess properties to serve as drug carriers to
4

directly target tumor cells and deliver drugs to localized areas with the desired concentration
[48]. The application of nano-drug delivery systems formulation can provide an increase of drug
bioavailability, stability, solubility, and a decrease in systemic toxicity [48].
1.4. Gold Nanoparticles
1.4.1 Physiochemical Properties of Gold Nanoparticles
Gold nanoparticles (AuNPs) play an important role in tumor targeting and treatment due
to their physicochemical characteristics. AuNPs are very stable, non-reactive, and cause no
toxicity issues in the body. They can be produced at nanoscale level and can be altered to
maintain certain conductivity and redox behavior [19]. Due to their different properties, AuNPs
are also widely used in sensing, imaging, diagnostics, and treatment [20]. AuNPs have been
shown to have antioxidant properties enabling them to be resistant to oxidation [20]. Masoud
Negahdary et al demonstrated that AuNPs with a diameter of 10 nm significantly decrease
catalase and glutathione peroxidase enzyme activities in mice [20]. Furthermore, AuNPs are
commonly used as photothermal agents based on their ability to react to light energy. Under
incident photon energy, the conduction electrons on the surface of the AuNPs oscillate
collectively at the resonance frequency creating a phenomenon called localized surface
resonance (LSPR) [21-24]. The LSPR enhances the electromagnetic field and extension
coefficient [25, 26]. Upon reaction to light energy, AuNPs absorb the photon energy, this energy
is then converted to kinetic energy or vibration energy expressed in terms of heat [25]. The
optical and thermal properties of AuNPs can be tuned to a particular wavelength useful in
photothermal therapy and photodynamic therapy.
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1.4.2 Applications of AuNPs in Tumor Diagnosis and Treatment
AuNPs have been used as a sensing mechanism to detect biomarkers in
neurodegenerative diseases, tissue regeneration, and cardiovascular diseases because of their
ability to absorb light and scatter light in the localized surface plasmon resonance frequencies
[27]. Their ability to be used as sensing can be explored in different areas. For example, in
colorimetry detection, aggregation of AuNPs by an analyte can lead to a change in color based
on the localized surface plasmon resonance band red-shifts. AuNPs have served as drug carriers
to low solubility and hydrophobic drugs. They can also be functionalized with different moieties
for targeted delivery [28]. Ramalingam et al have demonstrated that AuNPs have anticancer
properties against NSCLC cell lines as AuNPs were able to arrest cell cycle at G2/M phase
making gold an effective tool for treating lung cancer [49]. Overall, AuNPs have the potential to
help overcome the different challenges faced by current methods used to manage tumors.
1.4.3 Synthesis of AuNPs
The most used method to synthesize AuNPs was created in 1951 known as the Turkevich
method. In this procedure, AuNPs are stabilized with citrate ions [29]. Sodium citrate act as a
reducing and stabilizing agent in the synthesis to prevent any aggregation [29]. The initial step in
the synthesis of AuNPs starts with the reduction of tetrachloroauric acid (HAuCl4) to Au+3. A
ligand is usually used to stabilize the reaction and a reducing agent (sodium citrate) to reduce the
HAuCl4. Several different methods have been developed to obtain specific average size,
dispersity, and surface functionality. The shape and size of AuNPs impact their ability to
extravasate from the vasculature and target tumors. The optimized size, shape, and surface
modalities also affect the impact of the photothermal therapy due to the distribution of the heat
and clearance from the reticuloendothelial system (RES) [30]. Optimized nanomaterials can
6

bypass phagocytic cells in RES to minimize optimization and increase circulation half-life [54].
For example, PEGylated nanoparticles tend to have longer prolonged circulation in the body
which enhances drug delivery [54].
1.4.4 Toxicity of AuNPs
With the increasing use of AuNPs in biomedical applications, there have been concerns
about their potential toxicity effects. The biodistribution and bioactivity of AuNPs depend on
their physicochemical properties. Studies have found key parameters based on the surface
modification, the size, shape, and dose amount that can alter the biological effect of gold
nanoparticles [32]. The size of the AuNPs is dependent on their catalytic activity [51] and
cytotoxicity depends on the surface chemistry and morphology [33]. Negatively charged
nanoparticles tend to be less toxic than positively charged gold nanoparticles. Higher
concentrated nanoparticles may cause an adverse effect on cell proliferation, mortality, and
adhesive function.
1.5. Gold Nanoshells in Photothermal Therapy
The optical properties of gold nanoparticles are tunable by modifying their size, shape,
and surface chemistry [31]. Gold nanoshells are spherical AuNPs with different unique
physicochemical and mechanical properties that facilitate improvement in early tumor detection
and treatment. Gold nanoshell is composed of a dielectric core that is made of silica
nanoparticles with an outer shell layer made of AuNPs. Silica is an inert chemical with low
toxicity, high biodegradability capabilities, and strong mechanical properties, and is recognized
as not harmful and safe by the FDA [34]. Due to its known biocompatibility, silica has been very
desirable for pharmaceutical use. Silica is commonly used as a drug delivery system due to its
7

high drug loading capacity and its timely drug release [35]. The toxic effect of silica on the
immune system depends on the type of cells and the physiochemical properties of the silica [35].
Silica’s physiochemical properties depend on its synthesis and these properties are based on
shape, crystallinity, size, and composition [36]. Silica can have either an amorphous or
crystalline structure. The physical appearance of the silica colloids depends on their size; silica
colloids less than 10 nm in size have a clear color, silica between 10 and 20 nm in size are
opaque, and silica greater than 50 nm in size are white [36].
Combining the gold and silica properties, gold nanoshells can be used as a photothermal
treatment agent for cancer. Gold nanoshells are optically robust capable of absorbing light
energy at a certain wavelength while triggering the precise release of therapeutics drugs. The use
of NIR can provide photothermal therapy to kill cancer cells and offers much deeper tissue
penetration depth [37]. An effective photothermal range for biological therapeutic is between
800 and 1200 nm due to the light scattering and the absorption of water and tissues are lower
within this region allowing blood and tissue to be more transmissive. With controlled heating
produced from NIR emission, the gold nanoshells absorb the emitted light which is then released
in the form of heat resulting in photothermally induced cell death. [38, 47, 55]. Photothermal
therapy relies on increasing the temperature of targeted cancer cells to above 42⁰C for a set
duration of time to fatally injure tumor cells while avoiding the surrounding healthy cells.
Photothermal therapy has been used in different areas of medicine including physiotherapy,
cardiology, oncology, and ophthalmology [39]. In Photothermal therapy, heat is applied to
localized cells or tissue increasing the human body temperature above its baseline temperature
killing malignant cells and tissues [56].
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Gold nanoshells can be delivered in tumor tissue via the EPR effect due to the tumor
environment. The leaky tumor vasculature allows certain molecules to enter the tumor site [40].
Therefore nanoshells have the capability to be conjugated with other molecules, proteins,
antibodies, and thiol groups [42]. To further ensure uptake, gold nanoshells can be modified
through surface PEGylation and conjugation with thiol functional group. PEG or poly (ethylene
glycol) is a coiled synthetic and hydrophilic polymer offering steric repulsion of nanoparticles by
preventing aggregation and protein adsorption [43]. Thiol-modified PEGylated nanoshells have
the advantage in preventing rapid clearance through lymphatic system prolonging longer blood
circulation [40, 41]. Furthermore, studies have revealed that PEGylated nanoshells are more
stable than non-pegylated nanoparticles in reducing RES uptake [42].
In this study, we generated gold nanoshells for photothermal therapy to target and
eradicate A549 cell line. We hypothesized that the LSPR properties of the gold nanoshells along
with NIR exposure can cause thermal cell ablation and membrane damage.
To test our hypothesis, we first synthesized gold nanoshells with a silica core coated with
gold metal (figure 1). We synthesized gold nanoshells that ranged around 120 nm functionalized
with a linker, polydiallyldimethyl ammonium chloride (PDADMAC). A549 cells were incubated
with gold nanoshells and then exposed to NIR light at 850 nm for 7 and 30 min to induce cell
death. We aim to determine if gold nanoshells can induce cell death under prolonged NIR laser
light.
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Figure 1. Gold Nanoshells Synthesis

1.6 Rationale:
Gold nanoshells have high absorbance capabilities with high tunable plasmon resonance and can
induce oscillation at a certain wavelength. The absorbance of the laser light can convert the
photon energy into heat. This heat can increase the cancerous cells to their optimal temperature
to produce minimally invasive cell death.
1.7 Central Hypothesis:
Application of gold nanoshells can enhance NIR-based thermal ablation therapy in NSCLC cells
and promote minimal invasion and cell death as a therapeutic tool for cancer treatment.
1.8 Specific Aims:
•

To determine if gold nanoshells can be used as a therapeutic tool for cancer
treatment.

•

To determine if gold nanoshells can induce cell death when mediated with NIR
laser light.

•

To understand the effect of hyperthermia treatment on cancerous lung cells

10

CHAPTER TWO:
MATERIALS AND METHODS

2.1 Materials
All reagents for this research were purchased from Thermo Fisher Scientific and Sigma Aldrich.
Cell lines were purchased from American Type Culture Collection (ATCC).
Gold Nanoparticles: 80% Tetrakiss (hydroxymethyl) phosphonium in water (THPC) (Sigma
Aldrich404861-100ML) , Hydrogen tetrachloroaurate (III) (99.9%) (Sigma Aldrich520918-1G),
1 M NaOH, HPLC grade water (Sigma Aldrich), polydiallyldimethyl ammonium chloride
(PDADMAC) (Sigma Aldrich 409022-25ML).
Silica Nanoparticles: Ammonium Hydroxide (with 33% ammonia) (Sigma Aldrich AX1303-6),
ethanol (99% EtOH), TEOS (Si(OC2H5)4 or (tetraethyl orthosilicate) (Sigma Aldrich 86578250ML),
Gold and Silica Nucleation: Potassium carbonate (99%) (Sigma Aldrich 209619-100G),
formaldehyde (Sigma Aldrich).
Cell Line: A549/ATCC®CCL-185TM (American Type Culture Collection; State, USA)
Cell Culture Reagents: Fetal Bovine Serum (FBS), glutamine, penicillin, and streptomycin.
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Cell Study:5% glutaraldehyde (Sigma Aldrich G7776-10ML), silver enhancement kit (Sigma
Aldrich SE100-1KT), Dextran, Fluorescein (10,000 MW) (Thermo Fisher ScientificD1820,
CyQUANT™ MTT Cell Viability Assay (Thermo Fisher ScientificV13154).
Instrumentations: JEOL 1400 TEM; USF Microscopy Core, Ultrasonic, Zetasizer Nano series,
NIR laser light. NanoDrop Spectrometer, confocal microscope, fluorescent microscope,
ultrasonic bath sonicator, and homogenizer
2.2 Methodology
The synthesis of gold nanoshells was synthesized as previously described by Pham et al and
Ashayer et al. [44, 45].
2.2.1 Synthesis of Gold Nanoparticles
The HAuCl4 solution was prepared by mixing ~ 0.08504 g of hydrogen tetrachloroaurate (III) in
40 mL HPLC grade water ([27 mmol; 2% hydrogen tetrachloroaurate (III)]). HAuCl4 solution
was immersed in the ultrasonic bath for 10 min with no heat. In a 50-mL conical tube, 45 mL
HPLC grade water was mixed with 0.5 mL 1 N NaOH and 1 mL of 80% THPC (12 μl of 80%
THPC in 10 mL HPLC grade water). Solution was mixed with a strong vortex for 5 min. The
HAuCl4 solution was then added quickly to produce a red-wine color (Figure 2).
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Figure 2. Synthesis of Gold Nanoparticles. A. 2% solution of HAuCl4. B. Colloidal gold nanoparticles.

2.2.2 Synthesis of Silica Nanoparticles
The silica nanoparticle core was synthesized using the Stöber method by hydrolysis and
condensation of TEOS. Briefly, silica was prepared by mixing 3 mL of ammonium hydroxide
(with 28-30% NH3) with 50 mL of EtOH solution. 1.5 mL of TEOS was added dropwise to the
solution. The initial solution was clear then turned opaque after a few minutes and stirred
overnight. The final solution of silica nanoparticles appeared cloudy-white (Figure 3). The
solution was analyzed in TEM and Zetasizer.
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Figure 3. Synthesis of Silica. A. Solution after 1 minute. B. Solution after about 45 min. C. Solution after 12 h.

2.2.3 Functionalization
To initiate the functionalization, an aliquot of 75 μL PDADMAC was added to the 50 mL silica
nanoparticles solution and was stirred with a strong force for 2 h. The solution was heated at low
temperature until boiled for 1 h (~100⁰C). A small addition of ethanol was added to the solution
during heating to keep the volume constant due to evaporation. The solution was purified
through centrifugation (2000 rpm or 806 RCF for 30 min) and resuspended in 50 mL absolute
ethanol solution (Figure 4). The solution was analyzed in TEM for confirmation.
2.2.4 Nucleation of AuNPs to Silica Core
In a 50 mL conical tube, 2 mL of the silica nanoparticles mixture was added to 20 mL of the gold
colloidal and vortex for 3 min. To allow attachment of AuNPs to the silica nanoparticles, the
mixture was left at room temperature (RT) undisturbed overnight. The non-attached gold
particles were removed by centrifugation (2000 rpm or 806 RCF for 30 min). The supernatant
was removed, and light brown pellets were resuspended in HPLC grade water and sonicated for
30 min (Figure 4).
14

Figure 4. Gold Nanoshell functionalization and growth. A-D. Shows functionalization of gold nanoparticles in silica
nanoparticles. C, D. The solution was centrifuged and redispersed in HPLC water. E, F. Potassium carbonate and 1% HAuCl4. G.
Gold nanoshells formation. F. Gold nanoshells reduction after addition of formaldehyde

2.2.5 Growth of Complex
A potassium carbonate mixture was prepared by dissolving 25 mg in 100 mL of HPLC grade
water. An aliquot of 1.5 mL of 1% hydrogen tetrachloroaurate (III) was added to a potassium
carbonate mixture to create a colorless solution. Next, 20 mL of this potassium carbonate
solution was mixed with 1 mL of the gold and silica solution (Au/PDADMAC/silica) and stirred
vigorously until solution turned from purple to light pink (Figure 4E-4G). Then, 40 μL
formaldehyde (16%) was added and the solution turned blue after 5 min (Figure 4H). To confirm
the complex, the final gold nanoshells solution was analyzed in TEM.
15

2.2.6 Characterization of Gold Nanoshells.
Each sample of AuNPs, silica, and gold nanoshells (3 μL) were dispersed on different carbon
200 mesh grids and allowed to dry for 24 h at room temperature. The morphologies of the
synthesized nanoparticles were observed with TEM at an accelerating voltage of 80 kV with a
beam current of 56 UA. The micro-graphs of every sample were captured at different locations
on the grid. An image analysis software, ImageJ, was used to calculate the average size
distribution of ~200 particles.
2.2.7 Cell Uptake of Gold Nanoshells
A549 cells were used to evaluate the cellular uptake of gold nanoshells. They were seeded on 96well plates at a density of 3×103 and 4×103 cells/well in Dulbecco’s phosphate-buffered saline
medium with 10% FBS and 1% penicillin streptomycin. The cells were cultured for 24-48 h for
optimal logarithmic growth under a humidified atmosphere of 95% air with 5% CO2 at 37⁰C
(Figure 5). Treated cells were washed with PBS and incubated with the nanoshell-serum-free
medium at 37⁰C for 1 h. Control cells were incubated with serum-free media in the absence of
nanoshell for 1 h. Following 1 h, media was removed from treated-nanoshell cells and rinsed
with PBS to remove unbound nanoshells and resuspended in fresh pre-warmed serum-culture
medium. The same method was used for other experimental groups.
2.2.8 Cell Binding of Gold Nanoshells
In order to visualize the binding of gold nanoshells to the cells, the cell lines were fixed with
2.5% glutaraldehyde for 10 min and rinsed with HPLC grade water. The cells were exposed to a
prepared silver enhancement solution and analyzed via an inverted light microscope.
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Figure 5. Microscopy images of cells with nanoparticles. A. Control. B. Gold. C. Silica. D-F. Gold nanoshells (scale bar is 200
μm).

2.2.9 In Vitro Photothermal Nanoshell Therapy:
After the cells were incubated with nanoparticles for 1 h, cells were washed with PBS to remove
unbound nanoparticles and redispersed in fresh pre-warmed media. All cells were exposed to a
high-power NIR laser beam (Figure 6) at 11.0 Volts, 1.0 AMPS (850 nm, 160 mW/cm2) for 7
min and 30 min for photothermal damage and then incubated at 37⁰C with 5% CO2 for 1 h.
2.2.10 Cellular Membrane Damage:
After photothermal ablation, to observe the membrane damage, the cells were suspended in a
fresh 50 μL serum-free media, and 2 μL of dextran was added into each well. The cells were
incubated with the fluorescent dextran for 30 min, rinsed with PBS, and fixed with 5%
glutaraldehyde (50 μL) and 50 μL serum-free medium. The cells were observed using
fluorescent microscopy.
17

Figure 6. Schematic of NIR setup

2.2.11 Cell Proliferation
To access the cell metabolic activity, a colorimetric assay known as MTT (3-(4,5dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide was conducted to determine the cell
proliferation and viability. The live cells interact with the MTT and cleave MTT producing a
dark blue insoluble formazan product. After the photothermal damage, the cells were incubated
at 37⁰C with 5% CO2 for 1 h. After incubation, the media was discarded, and fresh pre-warmed
serum-free media (50 μL of) and MTT reagent solution (50 μL) was added into each well. The
cells were returned to the incubator for 3 h. After 3 h, MTT solvent (150 μL) was added into
each well. The 96-well plate was wrapped with aluminum foil and placed on a shaker for 15 min
as described by the manufacturer. The absorbance was read at 590 nm.
Data Analysis: Data was analyzed using ImageJ, Excel, and a two-sample t-test
18

CHAPTER THREE:
RESULTS AND DISCUSSION

3.1 Characterization
3.1.1 Characterization of Gold Nanoparticles
TEM was used to determine the morphology of the nanoparticles, which allows for a highenergy beam of electrons to transmit through the nanoparticle samples forming an image. The
average AuNPs diameter was determined by measuring about 200 individual gold nanoparticles.
Figure 7 shows the AuNPs (measured at different magnifications) had a spherical shape with an
average diameter of 4 ± 2 nm. Figure 8 shows the diameter distribution of the AuNPs having a
range of 3-5 nm in size. UV-visible spectroscopy was recorded using a nanodrop spectrometer
and the AuNPs displayed an average absorbance of 520 nm.

Figure 7: TEM images of GNPs (scale bar is 200 nm)
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Figure 8. Size distribution and UV-VIS spectrum of AuNPs.

3.1.2 Characterization of Silica Nanoparticles
After obtaining the images from TEM, the images were analyzed using ImageJ to the determine
size distribution of silica Nanoparticles. Figure 9 illustrates TEM images of silica nanoparticles
at various magnifications, it showed consistent monodispersed silica particles. The silica
nanoparticle had a uniform size and spherical shape with an average diameter of 115 nm. The
absorbance spectra of silica nanoparticles are displayed in figure 10 having a higher peak
between 200 and 250 nm. The addition of PDADMAC acted as a linker to attach the negatively
charged silica and negatively charged gold nanoparticles showed no effect on the silica shape nor
size (Figure 9. F). The synthesized silica nanoparticles later acted as the core to bind the gold
nanoparticles.
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Figure 9. TEM images of silica Nanoparticles. A-E Images of silica nanoparticles at various magnifications. F. Silica +
PDADMAC nanoparticles. (Scale bars for A=50 nm; B=200 nm; C=0.5 μm; D=2 μm, E=200 nm; F=50 nm)

Figure 10. Size distribution and UV-VIS spectrum of Silica NPs.
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3.1.3 Characterization of Gold Nanoshells
Characterization determines the tunable optical properties of gold nanoshells. The optical tuning
is determined by their structures and shape. In figure 11 (A and B), the imaged nanoshells consist
of a silica nanoparticles core having an average diameter of 115 nm covered by a gold layer with
a thickness of 5 nm, making the average size of the nanoshells 120 nm. Figure 11C demonstrated
minimal gold layer covering without the addition of formaldehyde, exhibiting incomplete
functionalization. SPR peak of the gold nanoshells is tuned at a high peak of 550 nm (Figure 12).
The gold nanoshells have SPR band in the visible and UV region. The synthesized nanoparticles
have increased intensity and figure 12 also demonstrated the diameter distribution of the
nanoshells, displaying the highest range of the synthesized nanoshells to be between 101 and 120
nm.

Figure 11. TEM images of gold nanoshells. A, B shows a uniform gold layer covering after the addition of formaldehyde. C.
Shows minimal gold layer. The scale bar is 50 nm.
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Figure 12. Size distribution and UV-VIS spectrum of gold nanoshells.

Table 1. Summary of Nanoparticles Characterization
Properties
Solvent
pH
TEM-average
diameter
Absorbance peak
Zeta Potential

Gold
HPLC water
12.40
4.1 ± 2 nm

Silica
Ethanol,
redispersed in
water
9.96
115 ± 11 nm

Gold Nanoshells
Potassium Carbonate 25
mg; carboxyl group;
redispersed in water
7.02
120 ± 16 nm

500-550 nm

200-250 nm

~ 550-800 nm

-31.6 mV

-52.9 mV

~ -60 mV

Table 1 shows characterization summary of all synthesized nanoparticles.
3.2. Photothermal Therapy Effect on Cells
The synthesized nanoshells were fabricated to have a high absorbing ability in the NIR region.
The data suggest the capability of nanoshells to induce thermal therapy in the lung cancer cells
relies on the cells' ability to uptake the nanoshells and the photothermal properties of nanoshells
to convert the light energy into heat and induce cell death.
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The study on the effect of photothermal energy on lung cancer cells was analyzed by
incorporating the cells with different treatments: gold nanoparticles, silica nanoparticles, and
gold nanoshells. To determine the cell viability percentage, MTT assay was used to measure the
absorbance of viable cells. The absorbance intensity is proportional to the percent of viable cells.
Figure 13 shows cell viability under NIR exposure of 7 min. The cell density for this group was
around 3,000 cells/well. According to the MTT assay result, cells treated with gold nanoshells
had more irreversibility cell death and membrane damage compared to the control group and
cells treated with silica and AuNPs. The percentage of cell viability amongst cells treated with
gold nanoshells was 43%. Figure 14 shows cell viability under NIR exposure of 30 min. The cell
density for this group was around 4,000 cells/well. The percentage of cell viability amongst cells
treated with gold nanoshells was around 20%.
Using the fluorescent dextran dye, the region of cell death is represented in green fluorescence.
The control cells which were irradiated with no gold nanoshells, showed no cell death
implicating that the laser light alone caused no cell death. Very little difference was observed in
silica and AuNPs treated cells. Figure 15 shows images of cells after NIR irradiation. Non-viable
cells are represented with green fluorescence. Cell treated with gold nanoshells were observed to
have more green fluorescence implicating more cell deaths compared to the other groups.
Figure 16 illustrates cells treated with gold nanoshells after NIR irradiation of 30 minutes. Nonviable cells were observed due to green fluorescent. More cell death was observed in areas with
direct exposure to the NIR light. Gold nanoshell treated cells had lower cell viability compared
to the control group.
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The high peak of the synthesized gold nanoshells was 550 nm. A laser with a wavelength in this
region would have led to more cell death as the gold nanoshells would have absorbed more
photon energy.

Figure 13. Cell viability for 3 min exposure.

Figure 24. Cell viability for 30 min exposure.
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Figure 15. Images of cells after 7 min NIR irradiation. Non-viable cells have green fluorescence.

Figure 16. Images of cells treated with only gold nanoshells after 30 min NIR irradiation. Non-viable cells have green
fluorescence.
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CHAPTER FOUR:
CONCLUSION
This study aimed to determine if gold nanoshells can be used as a therapeutic tool for cancer
treatment, to determine if gold nanoshells can induce cell death when mediated with NIR laser
light, and to understand the effect of hyperthermia treatment on cancerous lung cells. Gold
nanoshells have optical tunable properties enabling them to absorb and scatter light. Gold
nanoshells can be synthesized at a controllable size to enhance red-shift properties at absorbing
light. In this study, gold nanoshells were synthesized to have a spherical shape around 120 nm in
order to absorb NIR light in the 500-800 nm region.

All cells underwent photothermal therapy using a laser beam at comparable power exposure. The
continuous direct high-energy laser exposure to the cells enables the nanoshells to absorb the
high energy and convert it to heat. This heat was enough to increase the temperature of the cells
causing cellular ablation. The hyperthermia therapy with the gold nanoshells and NIR exposure
provided irreversible damages to cells treated with gold nanoshells. The cells irradiated with only
gold and silica nanoparticles had little to no cellular damage. The control cells resulted in no cell
death even after 30 minutes of laser ablation. Cells incubated with gold nanoshells led to cellular
damage as revealed by a fluorescent dextran dye. The SPR characteristic of gold nanoshells
proves an absorption of energy in the 500-800 nm range. This implies the energy absorption led
to a conversion of heat causing cell damage in NSCLC cell line.
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During this study, it was determined that an effective photothermal therapy relies on different
factors. Photothermal therapy relies on increasing the temperature of targeted cancer cells to
above the cells' baseline temperature for a set duration with a change of temperature of ~ 9 ± 5
⁰C. The duration and laser power also play an important role.

Gold nanoshells are becoming the forefront of medical research due to their optical properties,
controllable morphology, and biocompatibility. Based on the findings, gold nanoshells can be
synthesized to a particular shape and size to comprise optical tunable properties for therapeutic,
targeting cellular therapies, and molecular detection. The data support the use of gold
nanoparticles as a potential intervention for treating NSCLC.
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FUTURE PROSPECTS

For future studies, we plan to enhance the red-shift properties of gold nanoshells to absorb light
in the 1000-1200 nm range. We aim to determine if thiol-PEGylated nanoshells can increase
gold nanoshells colloid stability and increase drug bioavailability in targeted drug delivery for
lung cancer.
We also plan to conduct proof-of-concept experiments by using a preclinical mouse lung cancer
model to demonstrate the efficacy of hyperthermia treatment with PEGylated gold nanoshells in
reducing and targeting lung tumors locally without any cytotoxicity.
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